Real-World Data on First-Line Treatment of Hormone Receptor-Positive, HER2-Negative, Metastatic Breast Cancer in Brazil (BRAVE Study).
- DOI
- 10.1016/j.clbc.2025.05.020
- Published
- 2025 Dec
- Container
- Clinical breast cancer
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.clbc.2025.05.020,
title = {Real-World Data on First-Line Treatment of Hormone Receptor-Positive, HER2-Negative, Metastatic Breast Cancer in Brazil (BRAVE Study).},
author = {Werutsky G and Rosa DD and Reinert T and Barroso-Sousa R and Resende H and Signorini P and Cronemberger E and Fagundes JGM and Leal JHS and Guimarães MB and Vieira A and Weis LN and de Figueiredo JMB and Correa TS and Venero FC and Pauletto MM and Franche LMT and Bernardes MM and de Oliveira AHO and de Jesus RG and Gössling G and Bines J},
year = {2025},
journal = {Clinical breast cancer},
doi = {10.1016/j.clbc.2025.05.020},
url = {https://doi.org/10.1016/j.clbc.2025.05.020}
}RIS
TY - JOUR TI - Real-World Data on First-Line Treatment of Hormone Receptor-Positive, HER2-Negative, Metastatic Breast Cancer in Brazil (BRAVE Study). AU - Werutsky G AU - Rosa DD AU - Reinert T AU - Barroso-Sousa R AU - Resende H AU - Signorini P AU - Cronemberger E AU - Fagundes JGM AU - Leal JHS AU - Guimarães MB AU - Vieira A AU - Weis LN AU - de Figueiredo JMB AU - Correa TS AU - Venero FC AU - Pauletto MM AU - Franche LMT AU - Bernardes MM AU - de Oliveira AHO AU - de Jesus RG AU - Gössling G AU - Bines J PY - 2025 JO - Clinical breast cancer DO - 10.1016/j.clbc.2025.05.020 UR - https://doi.org/10.1016/j.clbc.2025.05.020 ER -
APA
G, W., DD, R., T, R., R, B., H, R., P, S., E, C., JGM, F., JHS, L., MB, G., A, V., LN, W., JMB, D. F., TS, C., FC, V., MM, P., LMT, F., MM, B., AHO, D. O., RG, D. J., G, G., & J, B. (2025). Real-World Data on First-Line Treatment of Hormone Receptor-Positive, HER2-Negative, Metastatic Breast Cancer in Brazil (BRAVE Study).. Clinical breast cancer. https://doi.org/10.1016/j.clbc.2025.05.020
Source records
- pubmed · retrieved 2026-09-25T21:38:28.572Z